Michael Schmidt

This inventor holds 2 USPTO granted patents. Top assignees: Max-Delbruck-Centrum Fur Molekulare Medizin, Max-Delbrueck-Centrum Fuer Molekulare Medizin. Active years: 2015-2016.

USPTO Granted Patents = 2

% Patents Active = 50.0

Average Co-Inventor Count = 6.5

ph-index = 1

Company Filing History:

1 out of 32

Max-Delbruck-Centrum Fur Molekulare Medizin

patents

1 out of 18

Max-Delbrueck-Centrum Fuer Molekulare Medizin

patents

Years Active: 2015-2016

Loading Chart...

2 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9512066 - Enhancers of protein degradation (2016-12-06),

2. 8974768 - Azo compounds reducing formation and toxicity of amyloid beta aggregation intermediates (2015-03-10),

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to [email protected]

4 patents pending (EPO):

Please report any incorrect information to [email protected]